from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2600/-

LFCtreatmentdescriptionclass of inhibitor

-0.516

Amikacinug/mL Amikacintranslation

-0.605

Cap5-10ug/mL Capreomycintranslation

-0.954

Rox10-50 ug/mL Roxithromycintranslation

0.362

SM2-5 ug/mL Streptomycintranslation

-1.242

Tet5-10 ug/mL Tetracyclinetranslation

-2.320

Rif0.2-5ug/mL Rifampicintranscription

-1.606

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.462

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.257

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.215

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.789

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.213

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.881

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.077

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.770

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.069

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.675

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.097

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.409

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.102

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.984

KCN5-20 ug/mL Potassium cyaniderespiration

0.231

NaN30.2-2 mM Sodium aziderespiration

0.997

Nigericin50 uM Nigericinrespiration

-0.705

TRC10-150 ug/mL Triclosanrespiration

-0.969

TRZ10-25 ug/mL Thioridazinerespiration

-0.764

Valinomycin0.5-10 uM Valinomycinrespiration

-0.018

ZnSO42 mM ZnSO4respiration

0.136

menadione6-10 ug/mL Menadionerespiration

0.231

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.045

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.540

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.346

NRP_1Non-replicating persistence stage 1dosRassociated

0.515

Amp0.2mg/mL AmpicillincellWall

0.174

Cephalexin20-100 ug/mL CephalexincellWall

-0.225

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.413

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.426

EMB10-20 ug/mL EthambutolcellWall

0.496

Eta12-40 ug/mL EthionamidecellWall

0.647

INH0.2-0.4 ug/mL IsoniazidcellWall

0.191

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.719

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.118

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.472

BZA0.12 mg/mL BenzamidearomaticAmides

0.460

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.277

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.003

H2O24 mM hydrogen peroxideDNAdamaging

0.573

Levo10 ug/mL LevofloxacinDNAdamaging

0.359

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.068

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.607

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.647

UVUV-irradiationDNAdamaging

-0.779

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.120

Antimycin12.5-50 ug/mL Antimycin A?

0.215

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

0.510

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.033

PA8240.2-2 ug/mL PA-824?

-1.031

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.239

Verapamil50 uM Verapamil?

0.662

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.106

methoxatin10-20 ug/mL Methoxatin?